A higher CD163+ macrophage count or an increase in M2/M1 Ratio in a variety of cancers indicates a poor prognosis or metastasis [8, 48], although it remains unclear how CD163 works in the protumoral activation of TAMs. This evidence concerns the gene CD163 and cancer.